![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. N-methyl-4-((4-(((3-methyl(methylsulfonyl)aminopyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
2. Pf-04554878
3. Vs-6063
1. 1073154-85-4
2. Pf-04554878
3. Vs-6063
4. 1345713-71-4
5. Defactinib (vs-6063, Pf-04554878)
6. N-methyl-4-((4-(((3-(n-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
7. N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide
8. 53o87ha2qu
9. Vs 6063
10. Benzamide, N-methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)-2-pyrazinyl)methyl)amino)-5-(trifluoromethyl)-2-pyrimidinyl)amino)-
11. Vs6063
12. N-methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
13. N-methyl-4-((4-(((3-methyl(methylsulfonyl)aminopyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
14. Defactinib [usan:inn]
15. Unii-53o87ha2qu
16. Defactinib [usan]
17. Defactinib [inn]
18. Defactinib (usan/inn)
19. Pf 04554878
20. Defactinib [who-dd]
21. Gtpl7910
22. Schembl1627234
23. Chembl3137331
24. Bdbm418817
25. Dtxsid901025937
26. Hms3740o13
27. Amy42170
28. Bcp11299
29. Ex-a1037
30. Ex-a1049
31. Mfcd25977806
32. Nsc778364
33. Nsc781450
34. Nsc782549
35. Nsc800089
36. S7654
37. Us10450297, Example 317
38. Us10450297, Example 318
39. Akos026750300
40. Zinc103297739
41. Ccg-269780
42. Cs-3410
43. Db12282
44. Nsc-778364
45. Nsc-781450
46. Nsc-782549
47. Nsc-800089
48. Sb17060
49. Ncgc00386425-06
50. Ncgc00386425-11
51. Ac-35820
52. As-17045
53. Da-34914
54. Da-45890
55. Hy-12289
56. Ft-0706351
57. Ft-0721609
58. J3.502.756d
59. D10618
60. A887883
61. J-690021
62. Q27077009
63. 7kd
64. N-methyl-4-({4-[({3- [methyl(methylsulfonyl)amino]pyrazin-2- Yl}methyl)amino]-5- (trifluoromethyl)pyrimidin-2- Yl}amino)benzamide (317)
65. N-methyl-4-(4-((3-(n-methylmethylsulfonamido)pyrazin-2-yl)methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)benzamide
Molecular Weight | 510.5 g/mol |
---|---|
Molecular Formula | C20H21F3N8O3S |
XLogP3 | 1.4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 8 |
Exact Mass | 510.14094222 g/mol |
Monoisotopic Mass | 510.14094222 g/mol |
Topological Polar Surface Area | 151 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 804 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |